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GRANULOCYTE POPULATION IN SYNOVIAL FLUIDVARIES IN PATIENTS
AFTER ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION AND
POSITIVILY CORRELATES WITH THE PROTEIN LEVELS OF A
PROINFLAMMATORY CYTOKINE, IL-1 BETA
M. Inoue y, K. Tsuji z, K. Nakamura x, H. Katagiri x, I. Sekiya k,
M. Okazaki y, T. Muneta{. y Tokyo Med. and Dental Univ., Dept. of Plastic,
Reconstructive and Aesthetic surgery, Tokyo, Japan; z Tokyo Med. and
Dental Univ., Dept. of Cartilage Regeneration, Tokyo, Japan; x Tokyo Med.
and Dental Univ., Section of Joint Surgery and Sports Med., Tokyo, Japan;
k Tokyo Med. and Dental Univ., Ctr. for Stem Cell and Regenerative Med.,
Tokyo, japan; { Tokyo Med. and Dental Univ., Joint Surgery and Sports
Med. and Dept. of Cartilage Regeneration, Tokyo, Japan
Purpose: Synovial ﬂuid is an interstitial ﬂuid secreted by ﬁbroblastic
cells in the synovial membrane. It is a highly viscous liquid containing
hyaluronic acid and various cytokines. The physiological functions of
synovial ﬂuid include reduction of friction, shock absorption, nutrient,
and waste transportation in the joint. In addition, previous studies
showed that multipotent mesenchymal cells, those are considered to
contribute the tissue regeneration, reside in synovial ﬂuid and the
number of these cells increased after joint injury. These data strongly
suggest that condition of synovial ﬂuid may greatly inﬂuence the
recovery process after joint injury or surgery as well as joint homeo-
stasis. Based on this idea, we believe that the dynamic analyses of the
cells reside in the synovial ﬂuid and the changes of cytokine contexts in
the synovial ﬂuid after anterior cruciate ligament reconstruction (ACL-
R) will be informative to prognosticate the healing process of each
patient.
Here we report that granulocyte population signiﬁcantly surged in
synovial ﬂuid at the early time point after ACL-R. Interestingly the levels
of granulocyte surge varied in patients and those were positively cor-
related with the levels of a proinﬂammatory cytokine, IL-1 beta.
Methods: This study was approved by the Ethics Committee of Tokyo
Medical and Dental University. All patients enrolled in this study, who
underwent ACL-R from April till November 2013 in our university
hospital, gave their full, written, informed consent for participation
prior to the operative procedure. Synovial ﬂuid was obtained just before
the surgery, at day3-5, and day18-19 post surgery from the patients (14
cases, female: 4male: 10,16-45 year-old, median 23.5 year-old). CD66b-
positive granulocyte population in synovial ﬂuid in each time point was
quantitated by ﬂow-cytemetry (BD FACS Verse). Quantitation of protein
levels of IL-1 beta in synovial ﬂuid was performed by ELISA (Quantikine
IL-1 beta ELISA kit, R and D systems, MN). Pearson’s correlation coef-
ﬁcient test were employed for the statistical analysis and values of p <
0.05 were considered signiﬁcant.
Results: Flow-cytometric analyses revealed that the population of
granulocytes signiﬁcantly surged around 5.4-fold at day 3 to 5 after
ACL-R (just before surgery: 5.60þ/-5.94%, n ¼ 3, day3-5 post surgery:
30.3þ/-25.6%, n ¼ 8, day18-19 post surgery: 6.41þ/-7.99%, n ¼ 2). ELISA
analyses indicated that average IL-1 beta level in synovial ﬂuid at day3-
5 post surgery was 6.01þ/-4.21ng/ml-synovial ﬂuid (n ¼ 11). Pearson’s
correlation coefﬁcient test indicated that the levels of IL-1 beta in
synovial ﬂuid were signiﬁcantly correlated with the population of
granulocytes after surgery (r ¼ 0.690, p<0.05).
Conclusions: Since typical ACL-R always creates both femoral and tibial
burr holes through the bone marrow cavity, it is not surprising that
granulocytes are recruited from bone marrow to synovial ﬂuid after
surgery. However interestingly, we observed that the population of
recruited granulocytes varied between the patients and that was pos-
itively correlated to the levels of IL-1 beta in synovial ﬂuid. Since neu-
trophils, those are the major components of granulocytes in bone
marrow, are the important cells to produce IL-1 beta in the inﬂamma-
tory lesion, we speculate that the severity of inﬂammation after ACL-R
might be regulated by the numbers of granulocytes recruited. Since the
severity of joint inﬂammation is closely related to the clinical con-
ditions, such as joint pain and the healing potential of each patient, our
data suggest the distinguished roles of granulocytes in these processes.
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THE THREE CHAINS OF HAPTOGLOBIN AS POTENTIAL DIAGNOSTIC
MARKERS OF OSTEOARTHRITIS DISEASE
C. Fernandez-Costa, V. Calamia, P. Fernandez-Puente, J. Mateos,
B. Rocha, L. Lourido, C. Ruiz-Romero, F.J. Blanco. Rheumatology Div.,
Proteomics Group-ProteoRed/ISCIII, INIBIC-CHUAC, A Coru~na, SpainPurpose: Haptoglobin (HPT) is a plasma protein that binds free
hemoglobinwith high afﬁnity and thereby inhibits its oxidative activity.
HPT exists in two allelic forms in the human population, which pro-
duces three known phenotypes. These depend on the HPT alpha chains
that are expressed (a1, a2 or both), whereas the b chain is always
present. In a previous proteomic study by our group, the three different
HPT chains were identiﬁed as altered in the serum of patients suffering
osteoarthritis (OA). The aim of this study is to verify the usefulness of
haptoglobin chains as serum biomarkers for this disease using two
independent methods.
Methods: The abundance of the three different HPT chains was eval-
uated by Western blotting on 30 serum samples, 15 OA and 15 controls.
The samples were obtained from anonymous donors in the Complejo
Hospitalario Universitario A Coru~na, Spain. The Western blot analysis
was performed with standard 15% polyacrylamide SDS-PAGE gels and
monoclonal antibodies against the b, a-1 and a -2 chains of haptoglobin.
The relative abundance of HPT chains was calculated by obtaining the
ratio of normalized densitometric values between OA and normal
samples. To verify the alteration of HPT a-2 chain in OA sera versus
controls by an orthogonal method, additional OA and control samples
were previously depleted with a chemical sequential depletion method
developed in our lab. Proteins in these samples were digested and
analyzed by multiple reaction monitoring technology (MRM) using a
nanoLC coupled to a 5500 QTRAP mass spectrometer. This experiment
was developed by triplicate per sample, and the mean areas obtained
were compared in the OA samples versus control. A standard of beta-
galactosidase was used as internal standard.
Results: Using Western blot analysis we detected the increase of the
HPT b chain in OA sera (ﬁgure 1), and relatively quantiﬁed this increase
as 2.22-fold by densitometric analysis of the blots (p ¼ 0.017). We also
found that the HPT a-1 chain was 1.4-fold increased in OA sera (p ¼
0.012), whereas the HPT a-2 chain was 0.7 decreased in OA sera versus
control, although without statistical signiﬁcance. Using the MRM
technique, we relatively quantiﬁed the decrease of the HPT a-2 chain
with a normalized area 0.4-fold decreased in OA vs control (p¼ 0.009).
With these data, we veriﬁed the OA-dependent increase of HPT a-1 and
b by Western blot analysis, and the decrease of a-2 chain was observed
by two different methods, MRM and Western blot.
Conclusions: We have been able to verify for the ﬁrst time the OA-
dependent alteration of the haptoglobin chains. These data suggest that
these chains might be potential OA biomarkers in sera. A further anal-
ysis on larger sample cohorts will be carried out to validate their sen-
sitivity and speciﬁcity.114
TOWARDS PERSONALIZED HEALTH CARE IN OA? IDENTIFICATION OF
OSTEOARTHRITIS (OA) PATIENTS INTO FOUR PHENOTYPIC CLASSES
DEPENDING ON THEIR LEVEL OF CARTILAGE DEGRADATION AND
CONNECTIVE TISSUE INFLAMMATION
A-C. Bay-Jensen y, A. Siebuhr y, L. Lindhardt Egsgaard z, O. Simonsen z,
T. Eskehave z, L. Arendt-Nilesen z, K. Kjaer Petersen z, H. Hoegh x,
M. Karsdal y. yNordic BioSci. A/S, Herlev, Denmark; zAalborg Univ.,
Aalborg, Denmark; xCCBR A/S, Ballerup, Denmark
Purpose: A subset of osteoarthritis patients experiences connective
tissue inﬂammation, which may or may not result from or in elevated
cartilage destruction. The aim of this study was to subdivide OA patients
into groups (phenotypes) according to the level of connective tissue
inﬂammation and turnover, and the level cartilage degradation by
measurement of serological biomarkers of matrix metalloproteinase
(MMP)-mediated collagen destruction. Each of the phenotypes was
then characterized by clinical outcome measures (WOMAC, KL) as well
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and autoimmunity by citrullinated vimentin.
Methods: The C4P-003 study included 204 symptomatic (VASpain >
10) knee OA patients (KL 1 to 4) and 71 subjects of same age and gender
distribution, with no signs of knee OA (VASpain<10, KL ¼ 0). Mean age
was 64.5 (42-80), BMI was 28.1 (18.5- 47.3) and there was 49 % female.
Following clinical outcomes were monitored; VASpain (0-10 cm),
radiographic assessment of both knees, OA functionality questionnaires
(WOMAC, EQ5D, LEQ), standard blood works (e.g. CRP), and vitals (BMI,
smoking, blood pressure). Serological biomarkers were measured by
competitive ELISA: MMP-mediated degradation fragments of type I, II
and III collagen; C1M (soft connective tissue), C2M (cartilage degrada-
tion) and C3M (ﬁbrogenesis), and MMP-generated fragment of cit-
rullinated vimentin (VICM). C2M and C1M were used as classiﬁcation
variables setting cut-offs at the medians (N ¼ 275); at 258 pmol/L and
40 nmol/L, respectively. Subjects were subdivided into quartiles: Q1,
low C2M/low C1M; Q2, low C2M/high C1M; Q3, high C2M/low C1M; Q4,
high C2M/high C1M. Kruskal-Wallis test used to compare the quartiles.
Results: Serum C1M and C2M were independent co-variables (rho ¼
0.08). When separating the subjects into quartiles the age, gender and
BMI distribution remained the same. WOMAC pain and function were
signiﬁcantly higher (p0.1). CRP as well as C3M levels were signiﬁcantly
higher (p<0.00001) in those patients with a high C1M level (Q2&Q4).
There was a tendency (p ¼ 0.079) towards lower level of VICM in
patients with both low level of C2M and C1M (Q1), as summarized in
the ﬁgure.
Conclusions: High soft tissue degradation was associated with
inﬂammation and ﬁbrosis, as validated for other disease pathologies.
However, patients with a high level of cartilage degradation, but with
low inﬂammation and ﬁbrosis experienced lower pain and better
function of their knee, indicating that cartilage degradation in itself is
independent of symptomatic OA. Patients with low cartilage and soft
tissue degradation had a signiﬁcantly lower level of citrullinated anti-
gens, reﬂecting a phenotype without an auto-immune component.
Interestingly, KL score was not associated with any of the groups.115
CARTILAGE TURNOVER IS REFLECTED BY THE METABOLIC
PROCESSING OF TYPE II COLLAGEN: A NOVEL SERUM MARKER OF
CHONDROCYTES ANABOLIC FUNCTION AND CARTILAGE REPAIR
N.S. Gudmann y, J. Wang z, S. Hoielt y, P. Chen x, T. Christiansen k,
O. Simonsen{, Q. Zheng x, M.A. Karsdal y, A.C. Bay-Jensen y. yNordic
BioSci., Herlev, Denmark; zNordicBioSci. China, Beijing, China; xNordic
BioSci. China, Beijing, China; kOrthopedic Dept. Z, Gentofte Univ. Hosp.,
Hellerup, Denmark; {Aalborg Univ. Hosp., Frederikshavn, Denmark
Purpose: There is a great medical need for regeneration of damaged
cartilage for the beneﬁt of OA patients. Consequently, there is an intense
search for safe anabolic treatment for articular cartilage. However, there
is a lack of tools to investigate the action of anabolic pathways in
chondrocytes. This constitutes a need for biomarkers, which can
quantify cartilage formation. The aim of the study was to develop an
ELISA (ProC2), which is speciﬁc for the beta splice variant of the N-
terminal type II procollagen (P2BNP). This splice variant is expressed in
healthy cartilage, whereas the expression of the 69 amino acids longeralpha splice variant (P2ANP) is associated with embryogenesis and
cartilage pathologies. We hypothesized that the beta splice variant is
the form that is needed for regeneration/repair of mature cartilage, thus
the effect of anabolic factors should result in the release of P2BNP.
Furthermore we investigated whether the P2BNP assay was able to
detect changes in collagen formation in an ex vivo bovine full-depth
cartilage explants model (BEX).
Methods: A competitive ELISA speciﬁcally measuring P2BNP was
developed applying amonoclonal antibody raised inmouse recognizing
the N-terminus of the N-terminal propeptide of collagen type II. The
assay was technically validated. The range of the assay was 1.25-
37nmol/L (intra-assay CV 6.87%, inter-assay CV 8.92%). Tests of linearity
and analytic sensitivity, speciﬁcity, and stability of human amniotic
ﬂuid, fetal bovine serum (FBS) and human serum from women over 60
years were evaluated in the assay. After coating streptavidin plates with
biotin-QDVRQPG samples were added together with the antibody. The
plates were thereafter incubated with EnVision. Tetramethyl benzini-
dine (TMB) was added. The TMB reactionwas stopped by adding H2SO4
and measured at 450 nm with 650 nm as the reference.
The BEX explants (approx. :12mg) were isolated from the femur condyle
and cultured for 3 weeks in serum free DMEM/F12 medium with 3
weekly changes. Supernatant was collected. Following anabolic factors
were applied: transforming growth factor (TGF)-b, ﬁbroblastic growth
factor (FGF)-2, and insulin like growth factor (IGF)-1 each in concen-
trations of 100, 10, 1, 0.1, 0.001ng/ml. Data are shown as mean [95%-CI]
or (SD). Two tailed Mann Whitney test was used to compare bars with
vehicle. The viability of the explants was tested by Alamar blue prior to
cytokine stimulation and at termination.
Results: The ProC2 assay was sensitive and speciﬁc for human/bovine
N-terminal of the procollagen type II seen by a 100% inhibition of the
signal with 150nmol/L selection peptide: peptides with the corre-
sponding rat/mouse or the human alpha splice variant sequence could
not displace the signal. High levels of P2BNP was quantiﬁed in human
amniotic ﬂuid (163-187,7nmol/L) and FBS (851-901nmol/L) and showed
excellent linearity (dilution range 1:2-1:64 and 1:20-1:160 with 100%
(SD 7.6) recovery). In contrast, serum P2BNP levels in the elderly
women were below the lower detection limit. No signiﬁcant matrix
effect was observed in serum or conditioned medium. In the medium
from BEX, it was found that TGF-b and IGF-1 signiﬁcantly induced
secretion of P2BNP in a dose-dependent manner compared to the
untreated (ﬁgure). This association was not seen when explants were
stimulated by FGF-2.
Conclusion:To our knowledge this is the ﬁrst assay which is able to
evaluate P2BNP excretion. The ProC2 assay seems to be a promising and
novel marker of collagen type II formation. The assay was both sensitive
and speciﬁc for the beta-splice variant of collagen type II. In addition the
assay was able to differentiate between P2BNP level in supernatant of
BEX explants stimulated by either TGF-b or IGF-1 compared to
untreated.116
MAGNETIC COLLECTION OF CTXII FROM SMALL VOLUMES OF
SYNOVIAL FLUID
E.G. Yarmola, Y. Shah, K.D. Allen. Univ. of Florida, Gainesville, FL, USA
Purpose: Molecular biomarker analysis in urine and serum has dem-
onstrated potential to diagnose osteoarthritis (OA) at an earlier stage
than traditional radiographic scans. Recent studies in horses suggest
biomarker analysis in synovial ﬂuid may detect OA changes prior to the
serum and urine analysis of the same biomarker. Clinically and in large
animals, synovial ﬂuid can be acquired through joint aspiration; how-
ever, the development of OA biomarkers in small animal models is
